Publications

Publications

365体育亚洲唯一官方入口 researchers publish on a wide array of topics that further our understanding of the field and focus on improving lives through research. Selected publications that communicate our findings, including books, peer-reviewed articles and technical reports, conference proceedings, and more are presented here.

2023

Sugarbaker P.H., Chang D., and Liang J.J. (2023).

ASO author reflections: Similar survival of all subtypes of mucinous appendiceal adenocarcinoma except the intermediate subtype which shows an improved survival.

Sugarbaker P.H., Chang D., and Liang J.J. (2023).

Similar survival among all subtypes of mucinous appendiceal adenocarcinoma except the intermediate subtype, which shows an improved survival.

Kay M.C., Duffy E.W., Sun B., and Borger C. (2023).

Comparing diet quality indices for low-income 24-month-old toddlers: Exploring changes driven by 2020–2025 Dietary Guidelines for Americans.

Nelson A.T., Harris A.K., Watson D., Miniati D., Finch M., Kamihara J., Mitchell S.G., Wilson D.B., Gettinger K., Rangaswami A.A., Campos J.M., Lederman S., Feltis B.A., Vasta L.M., Harney L.A., Stewart D.R., Dehner L.P., Messinger Y.H., Hill D.A., and Schultz K.A.P. (2023).

Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.

Ellison M.L., Reeder K.E., Stone R., Hayes M., Swanson S.J., and Bond G.R. (2023).

Individual Placement and Support (IPS) for high school aged youth: Provider perspective and practice.

Chandler J. and Kubisiak J. (2023).

Clinical and economic assessment in early-stage dementia by severity and amyloid-B status: A 5-year retrospective claims study of GERAS-US patients.

Shuter J., Weinberger A.H., Kahan A., Duitz D., Duitz J., Chander G., Kim R.S., and Stanton C.A. (2023).

People with HIV who smoke cigarettes non-daily.

Shrine N., Izquierdo A.G., Chen J., Packer R., Hall R.J., Guyatt A.L., Batini C., Thompson R.J., Pavuluri C., Malik V., Hobbs B.D., Moll M., Kim W., Tal-Singer R., Bakke P., Fawcett K.A., John C., Coley K., Piga N.N., Pozarickij A., Lin K., Millwood I.Y., Chen Z., Li L., Wijnant S.R.A., Lahousse L., Brusselle G., Uitterlinden A.G., Manichaikul A., Oelsner E.C., Rich S.S., Barr R.G., Kerr S.M., Vitart V., Brown M.R., Wielscher M., Imboden M., Jeong A., Bartz T.M., Gharib S.A., Flexeder C., Karrasch S., Gieger C., Peters A., Stubbe B., Hu X., Ortega V.E., Meyers D.A., Bleecker E.R., Gabriel S.B., Gupta N., Smith A.V., Luan J., Zhao J.H., Hansen A.F., Langhammer A., Willer C., Bhatta L., Porteous D., Smith B.H., Campbell A., Sofer T., Lee J., Daviglus M.L., Yu B., Lim E., Xu H., O'Connor G.T., Thareja G., Albagha O.M.E., Suhre K., Granell R., Faquih T.O., Hiemstra P.S., Slats A.M., Mullin B.H., Hui J., James A., Beilby J., Patasova K., Hysi P., Koskela J.T., Wyss A.B., Jin J., Sikdar S., Lee M., May-Wilson S., Pirastu N., Kentistou K.A., Joshi P.K., Timmers P., Williams A.T., Free R.C., Wang X., Morrison J.L., Gilliland F.D., Chen Z., Wang C.A., Foong R.E., Harris S.E., Taylor A., Redmond P., Cook J.P., Mahajan A., Lind L., Palviainen T., Lehtimäki T., Raitakari O.T., Kaprio J., Rantanen T., Pietiläinen K.H., Cox S.R., Pennell C.E., Hall G.L., Gauderman W.J., Brightling C., Wilson J.F., Vasankari T., Laitinen T., Salomaa V., Mook-Kanamori D.O., Timpson N.J., Zeggini E., Dupuis J., Hayward C., Brumpton B., Langenberg C., Weiss S., Homuth G., Schmidt C.O., Probst-Hensch N., Jarvelin M.R., Morrison A.C., Polasek O., Rudan I., Lee J.H., Sayers I., Rawlins E.L., Dudbridge F., Silverman E.K., Strachan D.P., Walters R.G., Morris A.P., London S.J., Cho M.H., Wain L.V., Hall I.P., and Tobin M.D. (2023).

Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk.

Scott N.A., Sadowski C., Vernon A., Arevalo B., Beer K., Borisov A., Cayla J.A., Chen M., Feng P.-J., Moro R.N., Holland D.P., Martinson N., Millet J.-P., Miro J.M., and Belknap R. (2023).

Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine.

Sargent J.D., Edwards K.C., Emond J., Tanski S., Taylor K.A., Pierce J.P., Goniewicz M.L., Niaura R., Anic G., Chen Y., Callahan-Lyon P., Gardner L.D., Thekkudan T., Borek N., Kimmel H.L., Cummings K.M., Hyland A., and Brunette M. (2023).

Author response to e-cigarettes and respiratory disorder: The broader research context.

Want to work with us?
You’ll be in great company.

About Us Careers

365体育亚洲唯一官方入口 Employees.
365体育亚洲唯一官方入口 Employee.
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Leadership Montgomery
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
SiriusXM
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
Toyota
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Maryland Baltimore Campus
University of Michigan
University System of Maryland
Explore Our Clients

Please wait...

Forbes 2023 Best Employers for Diversity Powered by Statista Forbes 2023 America's Best Mid-Size Employers Powered by Statista Forbes 2022 The Best Employers for Women Powered by Statista

365体育亚洲唯一官方入口 is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.